Follow
Nicholas J Loman
Nicholas J Loman
Professor of Microbial Genomics and Bioinformatics, University of Birmingham
Verified email at bham.ac.uk - Homepage
Title
Cited by
Cited by
Year
Reagent and laboratory contamination can critically impact sequence-based microbiome analyses
SJ Salter, MJ Cox, EM Turek, ST Calus, WO Cookson, MF Moffatt, ...
BMC biology 12, 1-12, 2014
28652014
Binning metagenomic contigs by coverage and composition
J Alneberg, BS Bjarnason, I De Bruijn, M Schirmer, J Quick, UZ Ijaz, ...
Nature methods 11 (11), 1144-1146, 2014
17532014
Nanopore sequencing and assembly of a human genome with ultra-long reads
M Jain, S Koren, KH Miga, J Quick, AC Rand, TA Sasani, JR Tyson, ...
Nature biotechnology 36 (4), 338-345, 2018
17422018
Performance comparison of benchtop high-throughput sequencing platforms
NJ Loman, RV Misra, TJ Dallman, C Constantinidou, SE Gharbia, J Wain, ...
Nature biotechnology 30 (5), 434-439, 2012
16792012
Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil
NR Faria, TA Mellan, C Whittaker, IM Claro, DS Candido, S Mishra, ...
Science 372 (6544), 815-821, 2021
14542021
Shotgun metagenomics, from sampling to analysis
C Quince, AW Walker, JT Simpson, NJ Loman, N Segata
Nature biotechnology 35 (9), 833-844, 2017
14302017
Real-time, portable genome sequencing for Ebola surveillance
J Quick, NJ Loman, S Duraffour, JT Simpson, E Severi, L Cowley, JA Bore, ...
Nature 530 (7589), 228-232, 2016
14042016
A complete bacterial genome assembled de novo using only nanopore sequencing data
NJ Loman, J Quick, JT Simpson
Nature methods 12 (8), 733-735, 2015
12632015
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
10312021
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England
E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ...
Nature 593 (7858), 266-269, 2021
10132021
Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples
J Quick, ND Grubaugh, ST Pullan, IM Claro, AD Smith, K Gangavarapu, ...
Nature protocols 12 (6), 1261-1276, 2017
9532017
Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations
R Andrew
Virological, 2020
7722020
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
7472022
An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar
ND Grubaugh, K Gangavarapu, J Quick, NL Matteson, JG De Jesus, ...
Genome biology 20 (1), 1-19, 2019
7052019
Telomere-to-telomere assembly of a complete human X chromosome
KH Miga, S Koren, A Rhie, MR Vollger, A Gershman, A Bzikadze, ...
Nature 585 (7823), 79-84, 2020
6362020
Evolution and epidemic spread of SARS-CoV-2 in Brazil
DS Candido, IM Claro, JG De Jesus, WM Souza, FRR Moreira, ...
Science 369 (6508), 1255-1260, 2020
6192020
Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data
E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ...
MedRxiv, 2020.12. 30.20249034, 2021
6072021
Establishment and cryptic transmission of Zika virus in Brazil and the Americas
NR Faria, J Quick, IM Claro, J Theze, JG de Jesus, M Giovanetti, ...
Nature 546 (7658), 406-410, 2017
6022017
Towards a genomics-informed, real-time, global pathogen surveillance system
JL Gardy, NJ Loman
Nature Reviews Genetics 19 (1), 9-20, 2018
5692018
High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity
NJ Loman, C Constantinidou, JZM Chan, M Halachev, M Sergeant, ...
Nature Reviews Microbiology 10 (9), 599-606, 2012
5452012
The system can't perform the operation now. Try again later.
Articles 1–20